In the combined analysis of CLIP-seq, RIP-seq and RNA-seq data, we identified multiple potential direct binding targets (BCL2L12, RBCK1, E2F4, and CDK16) that may involve in BUD31-mediated ovarian cancer cell survival and proliferation. This evidence concerns the gene BUD31 and ovarian carcinoma.